These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29804884)

  • 1. Breast cancer screening in young women.
    Desreux JAC
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():208-211. PubMed ID: 29804884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Møller MH; Lousdal ML; Kristiansen IS; Støvring H
    Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
    Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
    J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer screening imaging: what do we do].
    Balu-Maestro C; Chapellier C; Souci J; Caramella T; Marcotte-Bloch C
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):3-10. PubMed ID: 19850418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence to Support Screening Women in Their 40s.
    Ray KM; Price ER; Joe BN
    Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
    Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
    Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Screening, Mammography, and Other Modalities.
    Fiorica JV
    Clin Obstet Gynecol; 2016 Dec; 59(4):688-709. PubMed ID: 27741212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening update.
    Tria Tirona M
    Am Fam Physician; 2013 Feb; 87(4):274-8. PubMed ID: 23418799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we individualize breast cancer screening?
    Desreux J; Bleret V; Lifrange E
    Maturitas; 2012 Nov; 73(3):202-5. PubMed ID: 22981888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
    Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
    J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
    Wang WV; Tan SM; Chow WL
    Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organized or individual breast cancer screening: what motivates women?].
    Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
    Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer screening: an evidence-based update.
    Fuller MS; Lee CI; Elmore JG
    Med Clin North Am; 2015 May; 99(3):451-68. PubMed ID: 25841594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.